Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study

This publication has 19 references indexed in Scilit:

• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
  The Lancet, 2004
• Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
  The Lancet, 2003
• High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study
  Published by Elsevier ,2001
• Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in Men
  Archives of internal medicine (1960), 2001
• Plasma lipids and cardiovascular risk: a POSCH report
  Atherosclerosis, 2001
• Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
  Circulation, 2000
• Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)
  Circulation, 1998
• Cholesterol and Coronary Heart Disease: Predicting Risks by Levels and Ratios
  Annals of Internal Medicine, 1994
• Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)
  The American Journal of Cardiology, 1992
• Lipids and risk of coronary heart disease The Framingham Study
  Annals of Epidemiology, 1992